| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3868289 | The Journal of Urology | 2009 | 7 Pages |
Abstract
A noninvasive urine diagnostic assay that uses metalloproteinases with the Clinical Intervention Determining Diagnostic could lead to more efficient treatment in bladder cancer survivors by decreasing the number of negative cystoscopies (42%), allowing physicians to more selectively monitor those at high risk.
Keywords
MMPNEDNGALPPVpositive predictive valuenegative predictive valueBiologicalELISAEnzyme-linked immunosorbent assayUrinary bladder neoplasmsNeoplasm recurrenceneutrophil gelatinase-associated lipocalinmatrix metalloproteinaseMatrix metalloproteinasesUrinary bladderLocalNPV یا negative predictive valueTumor markers
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Cecilia A. Fernández, Matthew F. Wszolek, Kevin R. Loughlin, John A. Libertino, Ian C. Summerhayes, Anthony P. Shuber,